Ariceum Therapeutics jobs and careers
Berlin, Germany
About Ariceum Therapeutics
Ariceum Therapeutics is a privately held radiopharmaceutical firm in the clinical stage that specializes in the detection and targeted treatment of aggressive malignancies, such as neuroendocrine and other hard-to-treat cancers.177Lu-satoreotide tetraxetan (Satoreotide), the company's primary targeted systemic radiopharmaceutical therapy, isan antagonist of the somatostatin type 2 receptor (SSTR2), which is overexpressed in many neuroendocrine tumors. For the simultaneous diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, some aggressive tumors, and childhood cancer, which currently offers few treatment choices and a poor prognosis, we are developing satoreotide as a "theranostic" pair.
- Founded
- 2021
- Employees
- 11 to 50
- Total funding
- $47.8M
- Headquarters
- Berlin
Leadership
The top of Ariceum Therapeutics's org chart, with how many people report into each leader.
Manfred Ruediger
CEO of Ariceum Therapeutics GmbH
11 reports
Susanna Mesa
Chief Operating Officer
5 reports
Prachi Desai
Scientist
Pierre Jordaan
Director Pharmacovigilance
Aaron Block, MBA
Senior Director / Head of Strategy and Business Development
Marion H.
CMC Manager
Carina Graß
Scientist
Jobs at Ariceum Therapeutics
No open positions right now. Explore more companies on TheJobsMap.